Inflammation

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study
Xenofon Baraliakos, Juergen Braun, Atul Deodhar, Denis Poddubnyy, Alan Kivitz, Hasan Tahir, Filip Van den Bosch, Evie-Maria Delicha, Zsolt Talloczy, Anke Fierlinger

RMD Open Sep 2019, 5 (2) e001005; DOI: 10.1136/rmdopen-2019-001005
ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis
Ho Yin Chung, Eva Tsz Fung Chui, Kam Ho Lee, Helen Hoi Lun Tsang, Shirley Chiu Wai Chan, Chak Sing Lau

RMD Open Aug 2019, 5 (2) e001008; DOI: 10.1136/rmdopen-2019-001008
IL-6-PAD4 axis in the earliest phase of arthritis in knock-in gp130F759 mice, a model for rheumatoid arthritis
Ayano Yahagi, Taro Saika, Hiroyasu Hirano, Miwa Takai-Imamura, Fumio Tsuji, Hiroyuki Aono, Masanori Iseki, Yoshitaka Morita, Hideya Igarashi, Yukihiko Saeki, Katsuhiko Ishihara

RMD Open Jun 2019, 5 (2) e000853; DOI: 10.1136/rmdopen-2018-000853
Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis
Carol A Hitchon, Xiaobo Meng, Hani S El Gabalawy, Linda Larcombe

RMD Open Apr 2019, 5 (1) e000874; DOI: 10.1136/rmdopen-2018-000874
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
Cassandra Calabrese, Laura C Cappelli, Marie Kostine, Elizabeth Kirchner, Tawnie Braaten, Leonard Calabrese

RMD Open Apr 2019, 5 (1) e000906; DOI: 10.1136/rmdopen-2019-000906
Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritis
Juliane Schroeder, Kirsty Ross, Kathryn McIntosh, Shilan Jabber, Stuart Woods, Jenny Crowe, Janet Patterson Kane, James Alexander, Catherine Lawrence, Robin Plevin

RMD Open Jan 2019, 5 (1) e000711; DOI: 10.1136/rmdopen-2018-000711
Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
Jürgen Braun, Atul Deodhar, Robert Landewé, Xenofon Baraliakos, Corinne Miceli-Richard, Joachim Sieper, Erhard Quebe-Fehling, Ruvie Martin, Brian Porter, Kunal K Gandhi, Désirée van der Heijde, on behalf of the MEASURE 1 and MEASURE 2 study groups

RMD Open Nov 2018, 4 (2) e000749; DOI: 10.1136/rmdopen-2018-000749
Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases
Kerstin Klein

RMD Open Nov 2018, 4 (2) e000744; DOI: 10.1136/rmdopen-2018-000744
Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation
Kristiina Rajamäki, Salla Keskitalo, Mikko Seppänen, Outi Kuismin, Paula Vähäsalo, Luca Trotta, Antti Väänänen, Virpi Glumoff, Paula Keskitalo, Riitta Kaarteenaho, Airi Jartti, Nina Hautala, Päivi Jackson, Dan C Nordström, Janna Saarela, Timo Hautala, Kari K Eklund, Markku Varjosalo

RMD Open Oct 2018, 4 (2) e000740; DOI: 10.1136/rmdopen-2018-000740
Development of clinically apparent synovitis: a longitudinal study at the joint level during progression to inflammatory arthritis
Robin M ten Brinck, Hanna W van Steenbergen, Annette H M van der Helm-van Mil

RMD Open Sep 2018, 4 (2) e000748; DOI: 10.1136/rmdopen-2018-000748

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages